Biologic and Medical Imaging Reagents Industry Research Report 2023

Biologic and Medical Imaging Reagents Industry Research Report 2023


Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.

Highlights

The global Biologic and Medical Imaging Reagents market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).
The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.
In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.
On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biologic and Medical Imaging Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic and Medical Imaging Reagents.
The Biologic and Medical Imaging Reagents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologic and Medical Imaging Reagents market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic and Medical Imaging Reagents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Cardinal Health
Bracco
Bayer HealthCare
Curium Pharma
Hengrui Medicine
GE Healthcare
Lantheus Medical Imaging
Novartis (AAA)
Thermo Fisher Scientific
Jubilant DraxImage
PerkinElmer
Guerbet
Nihon Medi-Physics
YRPG

Product Type Insights

Global markets are presented by Biologic and Medical Imaging Reagents type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Biologic and Medical Imaging Reagents are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Biologic and Medical Imaging Reagents segment by Type
Nuclear Imaging (PET & SPECT) Reagents
Magnetic Resonance Imaging (MRI) Reagents
Fluorescence Imaging Reagents
Ultrasound and X-ray Contrast Reagents
Other

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Biologic and Medical Imaging Reagents market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Biologic and Medical Imaging Reagents market.
Biologic and Medical Imaging Reagents Segment by Application
Hospitals
Clinics
Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Biologic and Medical Imaging Reagents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic and Medical Imaging Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Biologic and Medical Imaging Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Biologic and Medical Imaging Reagents industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic and Medical Imaging Reagents.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biologic and Medical Imaging Reagents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Biologic and Medical Imaging Reagents by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Nuclear Imaging (PET & SPECT) Reagents
1.2.3 Magnetic Resonance Imaging (MRI) Reagents
1.2.4 Fluorescence Imaging Reagents
1.2.5 Ultrasound and X-ray Contrast Reagents
1.2.6 Other
2.3 Biologic and Medical Imaging Reagents by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospitals
2.3.3 Clinics
2.3.4 Other
2.4 Assumptions and Limitations
3 Biologic and Medical Imaging Reagents Breakdown Data by Type
3.1 Global Biologic and Medical Imaging Reagents Historic Market Size by Type (2018-2023)
3.2 Global Biologic and Medical Imaging Reagents Forecasted Market Size by Type (2023-2028)
4 Biologic and Medical Imaging Reagents Breakdown Data by Application
4.1 Global Biologic and Medical Imaging Reagents Historic Market Size by Application (2018-2023)
4.2 Global Biologic and Medical Imaging Reagents Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Biologic and Medical Imaging Reagents Market Perspective (2018-2029)
5.2 Global Biologic and Medical Imaging Reagents Growth Trends by Region
5.2.1 Global Biologic and Medical Imaging Reagents Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Biologic and Medical Imaging Reagents Historic Market Size by Region (2018-2023)
5.2.3 Biologic and Medical Imaging Reagents Forecasted Market Size by Region (2024-2029)
5.3 Biologic and Medical Imaging Reagents Market Dynamics
5.3.1 Biologic and Medical Imaging Reagents Industry Trends
5.3.2 Biologic and Medical Imaging Reagents Market Drivers
5.3.3 Biologic and Medical Imaging Reagents Market Challenges
5.3.4 Biologic and Medical Imaging Reagents Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Biologic and Medical Imaging Reagents Players by Revenue
6.1.1 Global Top Biologic and Medical Imaging Reagents Players by Revenue (2018-2023)
6.1.2 Global Biologic and Medical Imaging Reagents Revenue Market Share by Players (2018-2023)
6.2 Global Biologic and Medical Imaging Reagents Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Biologic and Medical Imaging Reagents Head office and Area Served
6.4 Global Biologic and Medical Imaging Reagents Players, Product Type & Application
6.5 Global Biologic and Medical Imaging Reagents Players, Date of Enter into This Industry
6.6 Global Biologic and Medical Imaging Reagents Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Biologic and Medical Imaging Reagents Market Size (2018-2029)
7.2 North America Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Biologic and Medical Imaging Reagents Market Size by Country (2018-2023)
7.4 North America Biologic and Medical Imaging Reagents Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Biologic and Medical Imaging Reagents Market Size (2018-2029)
8.2 Europe Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Biologic and Medical Imaging Reagents Market Size by Country (2018-2023)
8.4 Europe Biologic and Medical Imaging Reagents Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Biologic and Medical Imaging Reagents Market Size (2018-2029)
9.2 Asia-Pacific Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Biologic and Medical Imaging Reagents Market Size by Country (2018-2023)
9.4 Asia-Pacific Biologic and Medical Imaging Reagents Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Biologic and Medical Imaging Reagents Market Size (2018-2029)
10.2 Latin America Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Biologic and Medical Imaging Reagents Market Size by Country (2018-2023)
10.4 Latin America Biologic and Medical Imaging Reagents Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Biologic and Medical Imaging Reagents Market Size (2018-2029)
11.2 Middle East & Africa Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Biologic and Medical Imaging Reagents Market Size by Country (2018-2023)
11.4 Middle East & Africa Biologic and Medical Imaging Reagents Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Cardinal Health
11.1.1 Cardinal Health Company Detail
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Biologic and Medical Imaging Reagents Introduction
11.1.4 Cardinal Health Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.1.5 Cardinal Health Recent Development
11.2 Bracco
11.2.1 Bracco Company Detail
11.2.2 Bracco Business Overview
11.2.3 Bracco Biologic and Medical Imaging Reagents Introduction
11.2.4 Bracco Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.2.5 Bracco Recent Development
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Company Detail
11.3.2 Bayer HealthCare Business Overview
11.3.3 Bayer HealthCare Biologic and Medical Imaging Reagents Introduction
11.3.4 Bayer HealthCare Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.3.5 Bayer HealthCare Recent Development
11.4 Curium Pharma
11.4.1 Curium Pharma Company Detail
11.4.2 Curium Pharma Business Overview
11.4.3 Curium Pharma Biologic and Medical Imaging Reagents Introduction
11.4.4 Curium Pharma Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.4.5 Curium Pharma Recent Development
11.5 Hengrui Medicine
11.5.1 Hengrui Medicine Company Detail
11.5.2 Hengrui Medicine Business Overview
11.5.3 Hengrui Medicine Biologic and Medical Imaging Reagents Introduction
11.5.4 Hengrui Medicine Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.5.5 Hengrui Medicine Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Biologic and Medical Imaging Reagents Introduction
11.6.4 GE Healthcare Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.6.5 GE Healthcare Recent Development
11.7 Lantheus Medical Imaging
11.7.1 Lantheus Medical Imaging Company Detail
11.7.2 Lantheus Medical Imaging Business Overview
11.7.3 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Introduction
11.7.4 Lantheus Medical Imaging Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.7.5 Lantheus Medical Imaging Recent Development
11.8 Novartis (AAA)
11.8.1 Novartis (AAA) Company Detail
11.8.2 Novartis (AAA) Business Overview
11.8.3 Novartis (AAA) Biologic and Medical Imaging Reagents Introduction
11.8.4 Novartis (AAA) Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.8.5 Novartis (AAA) Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Introduction
11.9.4 Thermo Fisher Scientific Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Jubilant DraxImage
11.10.1 Jubilant DraxImage Company Detail
11.10.2 Jubilant DraxImage Business Overview
11.10.3 Jubilant DraxImage Biologic and Medical Imaging Reagents Introduction
11.10.4 Jubilant DraxImage Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.10.5 Jubilant DraxImage Recent Development
11.11 PerkinElmer
11.11.1 PerkinElmer Company Detail
11.11.2 PerkinElmer Business Overview
11.11.3 PerkinElmer Biologic and Medical Imaging Reagents Introduction
11.11.4 PerkinElmer Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.11.5 PerkinElmer Recent Development
11.12 Guerbet
11.12.1 Guerbet Company Detail
11.12.2 Guerbet Business Overview
11.12.3 Guerbet Biologic and Medical Imaging Reagents Introduction
11.12.4 Guerbet Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.12.5 Guerbet Recent Development
11.13 Nihon Medi-Physics
11.13.1 Nihon Medi-Physics Company Detail
11.13.2 Nihon Medi-Physics Business Overview
11.13.3 Nihon Medi-Physics Biologic and Medical Imaging Reagents Introduction
11.13.4 Nihon Medi-Physics Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.13.5 Nihon Medi-Physics Recent Development
11.14 YRPG
11.14.1 YRPG Company Detail
11.14.2 YRPG Business Overview
11.14.3 YRPG Biologic and Medical Imaging Reagents Introduction
11.14.4 YRPG Revenue in Biologic and Medical Imaging Reagents Business (2017-2022)
11.14.5 YRPG Recent Development
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings